Assessing Accuracy of the Freestyle Libre Pro Glucose Monitoring in Patients With Diabetes in a Critical Care Setting
NCT06800365 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2025-01-30
Summary
Currently, the standard of care for monitoring sugar levels in patients with diabetes in the intensive care unit is to use finger stick blood sugar monitoring. Finger stick blood sugar monitoring can be uncomfortable and time consuming. An alternate way to monitor sugar levels to use a sugar sensor, as part of the Abbott Freestyle Libre Flash glucose monitoring system, which has been approved for use outside of the hospital. The goal of the current research is to see whether using the sugar sensor gives accurate sugar readings in patients that are ill enough to be in the intensive care unit. If research confirms that the sensor is accurate, the investigators could potentially need to do fewer of those uncomfortable and time consuming blood sugar finger sticks.
At this time, the Freestyle Libre Flash Glucose Monitoring system is not available for purchase without a specific prescription for each individual patient and also is not available for purchase for research use from the manufacturer, Abbott Laboratories. However, the Freestyle Libre Pro sensor is available and uses the same measurement technology to measure interstitial glucose as the Libre Flash Glucose Monitoring system sensor (but does not require sensor scanning to retain glucose data). As such, the Libre Pro sensor will be utilized for the current study.
When a participant is enrolled in this study, they will have a Abbott Freestyle Libre Pro sensor applied to the back of their arm. They will continue to have finger stick glucoses checked as determined by their primary medical ICU team just as if they would if not enrolled in the study.
After the participant leaves the hospital, the data from their finger stick glucoses and from the Libre will be compared by a statistical analysis to see how similar or different the glucose readings from the finger stick glucoses are as compared to the Libre sensor data.
Conditions
- Diabetes Mellitus
- Critical Illness
- Continuous Glucose Monitoring
Interventions
- DEVICE
-
Sensor
The FreeStyle Libre Pro sensor is a device whereby a sensor is inserted into subcutaneous tissue (upper arm) and measures the interstitial blood glucose which is then available for later download. It comes pre-calibrated meaning that no fingerstick glucose monitoring is required to improve accuracy of the sensor.
Sponsors & Collaborators
- collaborator OTHER
-
Hennepin Healthcare Research Institute
lead OTHER
Principal Investigators
-
Laura Lafave, MD · Hennepin County Medical Center, Minneapolis
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-06
- Primary Completion
- 2021-09-21
- Completion
- 2021-09-21
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients
NCT00735163 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Critically Ill Patients
NCT00494455 ·Status: COMPLETED ·Phase: NA
-
Comparison of 2 Methods to Achieve Tight Glucose Control in Cardiovascular ICU Patients
NCT00636714 ·Status: COMPLETED ·Phase: PHASE4
-
Barriers to the Implementation of Complete Insulin Order Sets
NCT00813280 ·Status: COMPLETED
-
Relationship Between Blood Glucose Levels and Variability and Infections Development in Critically Ill Patient
NCT02659995 ·Status: UNKNOWN
-
Optimization of Glycemic Control in the Hospital and Critical Care Setting
NCT04015388 ·Status: COMPLETED
-
Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients
NCT03047824 ·Status: COMPLETED ·Phase: NA
-
GlucoClear ICU Study
NCT02238041 ·Status: WITHDRAWN
-
Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients
NCT07261865 ·Status: COMPLETED
-
Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
NCT00288743 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1
NCT00655460 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU
NCT02142088 ·Status: UNKNOWN ·Phase: NA
-
GlySure Acute Care Settings Study
NCT02421107 ·Status: UNKNOWN ·Phase: NA
-
LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness
NCT01420302 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Critically Ill Surgical Patients
NCT01108640 ·Status: COMPLETED
-
Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit
NCT00166491 ·Status: COMPLETED ·Phase: NA
-
Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality
NCT00871832 ·Status: COMPLETED
-
Evaluation of Continuous Glucose Monitoring in Patients With ACS and Type 2 Diabetes in ICU
NCT04822740 ·Status: TERMINATED ·Phase: NA
-
Investigation of Critically Ill Patients With Newly Diagnosed Diabetes
NCT05256043 ·Status: COMPLETED
-
MANAGE Automated Glucose Monitoring
NCT02211300 ·Status: UNKNOWN ·Phase: NA
-
Glycaemic Alterations in ICU
NCT02516358 ·Status: UNKNOWN
-
Freestyle Libre and Hospital Admissions in Type 2 Diabetes
NCT04997512 ·Status: UNKNOWN ·Phase: NA
-
Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit
NCT07088549 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Markers of Stress in Acute Ischemic Stroke With Hyperglycemia
NCT03318679 ·Status: COMPLETED
-
Tight Glycemic Control in Critical Care Patients
NCT00096421 ·Status: COMPLETED ·Phase: PHASE3